Scroll To Top
Search by Speciality

Vaccine Summit London

The O2 * | London, UK
From 195 to 545 GBP
Event Preview
This event
is Finished
Title: Vaccine Summit London
Specialty: Intensive Medicine
Dates: From Oct, 13, 2015 to Oct, 15, 2015
Location: London, UK
Type: Summit
Registration Cost: From 195 to 545 GBP
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for London, Uk.
General Info
Event Venue:

The O2 *

London, UK Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Now in its third year, this international interdisciplinary event is an open forum for discussion of all scientific and clinical aspects of vaccine development and vaccinations.  Using a multi-professional and inter-specialty approach this event offers plenty of opportunity  for networking and debate, and will bring you up to date with current research and thinking.

Hashtag: #Vac2015

This event has an open abstract session.  

Abstracts can be submitted on any subject related to vaccines and vaccination

The Deadline for abstract submissions for oral presentation is July 20th 2015

Abstracts for poster presentation only can be submitted up to two weeks before the event

You can download the instructions for authors at

This event has CPD accreditation

Who Should Attend

Public and animal health scientists 

Scientists developing, or with an interest in, new or enhanced vaccine adjuvants 

Individuals interested in novel vaccine delivery systems

Individuals establishing diagnostic assays for viruses. 

Epidemiologists, virologists, immunologists, R&D, pre-clinical vaccinologists

Basic scientists, industrial experts, and clinicians with an interest in the science of viral co-infection.

Talks Include:

Effect of oil adjuvants on integrity of foot-and-mouth disease virus vaccine antigens

Dr. Michiel M. Harmsen, Scientist, Central Veterinary Institute Wageningen UR, Division Virology, Lelystad, The Netherlands

Therapuetic use of vaccine for treatment of chronic hepatitis B: from bench to bedside

Dr. Sheikh Mohamad Fazle Akbar, MBBS, MD, PhD, Principal Investigator, Toshiba General Hospital, Tokyo, Japan

Synthetic biologic approaches and technologies for inducing an immune response against tumor antigens

Dr Jonathan Lewis, Ziopharm Oncology, Boston, United States

Integration of biology and mathematical modelling towards a better understanding of pathogen behaviour and rational design of improved bacterial vaccines.

Dr Piero Mastroeni, Reader in Infection and Immunity, University of Cambridge, United Kingdom

Dengue virus NS1protein as a vaccine target: risks and benefits

Dr Jaime Henrique Amorim, Laboratoty for Vaccine Development, Biomedical Sciences Institute, University of São Paulo, Brazil.

Oncolytic activity of attenuated Measles virus against mesothelioma

Dr Jean-François FONTENEAU, Chargé de recherche INSERM, INSERM UMR892, CNRS UMR6299, Institut de Recherche en Santé de l'Université de Nantes, France

Oral vaccines for the control of poultry diseases.

Professor Anthony Amaechi ATTAMA, Department of Pharmaceutics, University of Nigeria, Nsukka, Nigeria

Investigation of antibodies generated in response to vaccination with a HCMV gB subunit vaccine

Dr Gary R McLean, Imperial College London & London Metropolitan University, London, UK

Why do parents who usually vaccinate their children hesitate or refuse? General good vs. individual risk

Dr Anat Gesser-Edelsburg, Head of Health Promotion Department, School of Public Health, University of Haifa, Israel

HIV-1 vaccine: Where have we gone wrong?

Dr Cynthia L. Bristow, Chief Executive Officer, Alpha-1 Biologics, New York , USA

Plant-derived vaccines

Dr Athleen Hefferon, University of Toronto, Ont., Canada

Mucosal tolerance in preventing recurrent heart disease

Emeritus Professor Vijay Kakkar, President, Thrombosis Research Institute, London, UK

Patient Safety: Using technology to select the  right vaccine, right person, right schedule.

Dr Adrienne Willcox, Health Team Ltd., Glos, UK

Russian vaccines against especially dangerous bacterial pathogens

Dr Valentina A Feodorova, Saratov, Russia

Overview of assays for influenza vaccines immunology evaluation and correlates of protection

Professor Emanuele Montomoli, Dept. of Molecular and Developmental Medicine, University of Siena, Italy

Evolutionary Therapy: Immunotherapy As Personalized Medicine

Dr Ravi A. Madan, Clinical Director, Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, USA


Mr Muhammad Hoque, University of KwaZulu-Natal (Westville Campus), Durban, South Africa

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2015-08-21 To: 0--
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


Cineworld: The O2 

Peninsula Square


SE10 0DX

United Kingdom

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Also Part of the Euroscicon Group


Media Sponsors

Organising Agency


Phone: (+44) 07507 799380
Event map
Revelant Events